Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL351789 | 0.95 | USP2 (0.50) | USP2TSHRMAPK1MEN1KMT2A | |
| SCHEMBL24855300 | 0.91 | USP2 (0.53) | USP2TSHRMAPK1MEN1KMT2A | |
| SCHEMBL350840 | 0.89 | TSHR (0.53) | USP2TSHRMAPK1MEN1KMT2A | |
| SCHEMBL25902360 | 0.86 | USP2 (0.48) | USP2TSHRMEN1KMT2AHTT | |
| SCHEMBL58458 | 0.85 | USP2 (0.63) | USP2TSHRMEN1KMT2AHTT | |
| SCHEMBL5021533 | 0.84 | MEN1 (0.61) | USP2TSHRMAPK1MEN1KMT2A | |
| SCHEMBL3542017 | 0.84 | MEN1 (0.61) | USP2TSHRMAPK1MEN1KMT2A | |
| SCHEMBL18251584 | 0.84 | MEN1 (0.61) | USP2TSHRMAPK1MEN1KMT2A | |
| SCHEMBL10711302 | 0.84 | TSHR (0.67) | USP2TSHRMAPK1MEN1KMT2A | |
| SCHEMBL25902370 | 0.84 | USP2 (0.47) | USP2TSHRMEN1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002696-A1 | FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM | SHOWA DENKO K.K. (JP) | 2023-01-05 | — | — | US | disclosed |
| US-10803898-B2 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | SHOWA DENKO K.K. (JP) | 2020-10-13 | — | — | US | disclosed |
| US-20180047419-A1 | FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM | SHOWA DENKO K.K. (JP) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10803898-B2 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | AFF2, AFF1, AFF4 | USP2 4043/4885TSHR 1143/4885MAPK1 119/4885 |
| US-20230002696-A1 | FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM | AFF1, AFF2, PHOSPHO1 | USP2 2172/4885TSHR 1264/4885MAPK1 94/4885 |
| US-20180047419-A1 | FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM | AFF1, AFF2, AFF4 | USP2 4128/4885TSHR 1275/4885MAPK1 73/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.